Theratechnologies Inc Revenue Growth Rates (THTX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Theratechnologies Inc   (NASDAQ: THTX)
 

THTX's Revenue Growth by Quarter and Year

Theratechnologies Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

THTX Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 85.87
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 85.87

THTXs Annual Revenue
Theratechnologies Inc 's Revenue in the fiscal year 2024 $ 85.87 millions
Theratechnologies Inc 's Revenue in the fiscal year 2023 $ 81.76 millions
Theratechnologies Inc 's Revenue in the fiscal year 2022 $ 80.06 millions
Theratechnologies Inc 's Revenue in the fiscal year 2021 $ 69.82 millions
Theratechnologies Inc 's Revenue in the fiscal year 2020 $ 66.05 millions




THTX Revenue fourth quarter 2024 Y/Y Growth Comment
Theratechnologies Inc reported Revenue growth of 5.02% year on year in the fourth quarter 2024, to $ 85.87 millions, this is lower than Theratechnologies Inc 's recent average Revenue improvement of 29.34%.

Looking into fourth quarter 2024 results within Major Pharmaceutical Preparations industry 59 other companies have achieved higher Revenue growth. While Theratechnologies Inc ' s Revenue increase of 5.02% ranks overall at the positon no. 446 in the fourth quarter 2024.


THTX Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December 5.02 % 29.33 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   5.02 % 29.33 % - -

Financial Statements
Theratechnologies Inc 's fourth quarter 2024 Revenue $ 85.87 millions THTX's Income Statement
Theratechnologies Inc 's fourth quarter 2023 Revenue $ 81.76 millions Quarterly THTX's Income Statement


THTX Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   5.02 % 29.33 % - -


Back to THTX Growth rate Comparisons >> Back to THTX Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #60
Healthcare Sector #119
Overall #446

Revenue Y/Y Growth Statistics
High Average Low
29.34 % 29.34 % 29.34 %
(Nov 30 2023)  
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #60
Healthcare Sector #119
Overall #446
Revenue Y/Y Growth Statistics
High Average Low
29.34 % 29.34 % 29.34 %
(Nov 30 2023)  

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Theratechnologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


THTX's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


THTX's IV. Quarter Q/Q Revenue Comment


Theratechnologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Nov 30 2024)		 12 Months Ending
(Nov 30 2023)		 12 Months Ending
(Nov 30 2022)		 12 Months Ending
(Nov 30 2021)		 12 Months Ending
(Nov 30 2020)
Cumulative Revenue 12 Months Ending $ 85.87 $ 81.76 $ 80.06 $ 69.82 $ 66.05
Y / Y Revenue Growth (TTM) 5.02 % 2.13 % 14.66 % 5.71 % 4.49 %
Year on Year Revenue Growth Overall Ranking # 446 # 563 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 5.02 % 2.13 % 14.66 % 5.71 % 4.49 %
Seq. Revenue Growth (TTM) Overall Ranking # 446 # 563 # 0 # 0 # 0


Cumulative Revenue growth Comment
Although Theratechnologies Inc 's Annual Revenue growth year on year were below company's average 29.34% , Revenue announced in the Nov 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.02% year on year, from 2.13% in Nov 30 2023.

In the Healthcare sector 118 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 446, from total ranking in previous quarter at 563.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 60
Healthcare Sector # 119
Overall # 446

Revenue TTM Y/Y Growth Statistics
High Average Low
29.34 %
 29.34 %
29.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 60
Sector # 119
S&P 500 # 446
Cumulative Revenue growth Comment
Although Theratechnologies Inc 's Annual Revenue growth year on year were below company's average 29.34% , Revenue announced in the Nov 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.02% year on year, from 2.13% in Nov 30 2023.

In the Healthcare sector 118 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 446, from total ranking in previous quarter at 563.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 60
Healthcare Sector # 119
Overall # 446

Revenue TTM Y/Y Growth Statistics
High Average Low
29.34 %
29.34 %
29.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 60
Sector # 119
S&P 500 # 446




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
THTX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Nov 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Nov 30 2024
Cerus Corporation8.70%$ 8.701 millions
Indivior Pharmaceuticals Inc 8.69%$ 8.692 millions
Aveanna Healthcare Holdings Inc 8.57%$ 8.569 millions
Accuray Incorporated8.41%$ 8.410 millions
Quanterix Corporation8.37%$ 8.365 millions
Streamex Corp 8.33%$ 8.333 millions
Trinity Biotech Plc8.31%$ 8.310 millions
Orthofix Medical Inc 8.01%$ 8.013 millions
Addus Homecare Corp7.92%$ 7.924 millions
Medpace Holdings Inc 7.66%$ 7.662 millions
Elutia Inc 7.64%$ 7.643 millions
Dexcom Inc 7.63%$ 7.634 millions
Nature s Sunshine Products inc 7.62%$ 7.623 millions
Adm Tronics Unlimited Inc 7.61%$ 7.612 millions
Plus Therapeutics Inc 7.54%$ 7.540 millions
Bristol myers Squibb Company7.54%$ 7.537 millions
Jazz Pharmaceuticals Plc7.53%$ 7.534 millions
Abbott Laboratories7.16%$ 7.158 millions
Myriad Genetics Inc 7.02%$ 7.019 millions
Icu Medical Inc7.01%$ 7.008 millions
Mimedx Group Inc 7.00%$ 6.995 millions
P3 Health Partners Inc 6.87%$ 6.869 millions
Merck and Co Inc 6.79%$ 6.787 millions
Theravance Biopharma inc 6.77%$ 6.769 millions
Globus Medical Inc 6.61%$ 6.611 millions
Infusystem Holdings Inc6.54%$ 6.537 millions
Waters Corporation6.50%$ 6.497 millions
Gilead Sciences Inc 6.40%$ 6.396 millions
Bausch Health Companies Inc 6.27%$ 6.271 millions
Ati Physical Therapy Inc 6.14%$ 6.145 millions


About Theratechnologies Inc Revenue Growth Rates (THTX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Theratechnologies Inc (CIK 1512717).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-25-035910
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Theratechnologies Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.